Lovas Katrina Houde - May 31, 2023 Form 4 Insider Report for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

Role
Director
Signature
/s/ Aaron Perlitsh, Attorney-In-Fact for Kathy Houde
Stock symbol
LFCR
Transactions as of
May 31, 2023
Transactions value $
$0
Form type
4
Date filed
6/1/2023, 06:57 PM
Previous filing
Jun 1, 2023
Next filing
Jun 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFCR Common Stock Options Exercise +9.47K +41.74% 32.2K May 31, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LFCR Restricted Stock Unit Options Exercise $0 -9.47K -100% $0.00* 0 May 31, 2023 Common Stock 9.47K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
F2 The restricted stock units vested on May 31, 2023.